B90.9 Sequelae of respiratory and unspecified tuberculosis

Name of the Condition

• Sequelae of respiratory and unspecified tuberculosis

Summary

Sequelae of respiratory and unspecified tuberculosis refers to the residual effects or complications that persist after the active phase of tuberculosis (TB) infection involving the respiratory system or unspecified sites has resolved. These sequelae can include structural damage, functional impairment, or chronic symptoms resulting from prior tissue damage during the active disease phase. The condition encompasses long-term consequences such as scarring, fibrosis, or persistent symptoms due to the initial infection.

Causes

Sequelae of respiratory and unspecified tuberculosis arise from the damage caused by the initial Mycobacterium tuberculosis infection. During the active phase, the bacteria can destroy tissue in the lungs or other respiratory structures, leading to scarring, fibrosis, or structural changes. Even after the infection is cured, these changes may persist, resulting in chronic symptoms or functional limitations. The specific sequelae depend on the extent and location of involvement during the active infection.

Risk Factors

• History of active tuberculosis infection, particularly if treatment was delayed or incomplete.
• Severe or disseminated TB during the active phase, which increases the risk of extensive tissue damage.
• Involvement of critical respiratory structures (e.g., lungs, airways) during the initial infection.
• Underlying conditions that may have contributed to severe disease or delayed recovery.

Symptoms

Symptoms vary based on the affected tissues and may include chronic cough, shortness of breath, chest pain, or persistent respiratory symptoms. Unspecified sequelae may present with non-specific signs depending on the original infection site.

Diagnosis

Diagnosis involves reviewing the patient's history of prior tuberculosis infection and assessing current symptoms. Imaging (e.g., chest X-rays or CT scans) may reveal residual structural changes. Clinical evaluation focuses on identifying persistent effects of the initial infection, with no active TB confirmed at the time of assessment.

Treatment Options

Treatment is tailored to manage symptoms and address functional impairments. This may include respiratory therapies, medications for symptom relief, or interventions to improve organ function. Management focuses on optimizing quality of life and addressing complications from prior tissue damage.

Prognosis and Follow-Up

Prognosis depends on the extent of residual damage and the organs involved. Regular follow-up is important to monitor for worsening symptoms or new complications. Long-term care may be required to manage chronic effects and prevent further deterioration.

Complications

Potential complications include progressive respiratory dysfunction, recurrent infections, or worsening of structural damage. Unspecified sequelae may lead to non-specific health issues depending on the original infection site.

Lifestyle & Prevention

Lifestyle modifications, such as avoiding respiratory irritants or maintaining overall health, may help manage symptoms. Prevention focuses on ensuring complete treatment of active TB to reduce the risk of sequelae.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new respiratory issues develop, or there are signs of deteriorating function. Prompt evaluation is important for addressing complications or adjusting management plans.

Tips for Medical Coders

Document the history of prior tuberculosis infection and confirm the absence of active disease at the time of coding. Ensure the code B90.9 is used only when sequelae are attributed to respiratory or unspecified tuberculosis, with clear clinical correlation to the residual effects.